Intelligent drug supply chain: Creating value from AI

This week we launched the fourth in our series of reports highlighting the impact of artificial intelligence (AI) across the biopharma value chain. Our report, Intelligent drug supply chain: Creating value from AI, explores the digital transformation of biopharma’s global supply chains and how AI can help improve value and manage risks more effectively.

Source : https://blogs.deloitte.co.uk/health/2020/06/intelligent-drug-supply-chain-creating-value-from-ai.html

Date : July 14, 2020 at 07:04PM

Tag(s) : Acteurs